Cargando…
An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
BACKGROUND: Data on the long-term efficacy, safety, and tolerability of risperidone in adolescents with schizophrenia are limited. The objective of this study was to evaluate the efficacy and safety of maintenance risperidone treatment in adolescents with schizophrenia. METHODS: This open-label stud...
Autores principales: | Pandina, Gahan, Kushner, Stuart, Karcher, Keith, Haas, Magali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489792/ https://www.ncbi.nlm.nih.gov/pubmed/22676070 http://dx.doi.org/10.1186/1753-2000-6-23 |
Ejemplares similares
-
Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
por: Ganguli, Rohan, et al.
Publicado: (2008) -
Cognitive functioning in adolescents with schizophrenia treated with paliperidone extended-release: 6-Month exploratory analysis from an open-label, single-arm safety study()
por: Pandina, Gahan, et al.
Publicado: (2020) -
Are the Long-Acting Intramuscular Formulations of Risperidone or Paliperidone Palmitate Associated with Post-Injection Delirium/Sedation Syndrome? An Assessment of Safety Databases
por: Alphs, Larry, et al.
Publicado: (2011) -
Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD
por: Pandina, Gahan J, et al.
Publicado: (2007) -
Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study
por: Gianfrancesco, Frank D, et al.
Publicado: (2009)